investorscraft@gmail.com

Intrinsic ValueCNO Financial Group, Inc. (CNO)

Previous Close$39.25
Intrinsic Value
Upside potential
Previous Close
$39.25

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

CNO Financial Group, Inc. operates as a holding company for a group of insurance subsidiaries, primarily serving middle-income pre-retiree and retired Americans through life, health, and annuity products. The company generates revenue through premiums, investment income, and fee-based services, with a focus on niche markets underserved by larger competitors. CNO’s market positioning is reinforced by its multi-channel distribution strategy, including independent agents, direct marketing, and worksite partnerships, allowing it to maintain a competitive edge in the middle-market segment. The company’s product portfolio includes Medicare supplements, long-term care insurance, and fixed-indexed annuities, catering to the financial security needs of an aging demographic. CNO’s disciplined underwriting and cost management practices further strengthen its ability to deliver consistent profitability in a highly regulated and competitive industry.

Revenue Profitability And Efficiency

CNO reported revenue of $4.45 billion for the period, with net income of $404 million, reflecting a net margin of approximately 9.1%. Diluted EPS stood at $3.74, supported by strong premium growth and disciplined expense management. Operating cash flow was robust at $627.7 million, indicating efficient cash conversion from core operations. The absence of capital expenditures suggests a capital-light business model focused on underwriting and investment activities.

Earnings Power And Capital Efficiency

The company’s earnings power is driven by its ability to generate stable investment income and underwriting profits, with a focus on risk-adjusted returns. CNO’s capital efficiency is evident in its ability to maintain profitability while managing a diversified product mix. The diluted EPS of $3.74 underscores its capacity to deliver shareholder value through disciplined capital allocation and operational execution.

Balance Sheet And Financial Health

CNO’s balance sheet shows $1.66 billion in cash and equivalents, providing liquidity to meet policyholder obligations and strategic initiatives. Total debt of $4.52 billion reflects leverage used to support growth and investment activities. The company’s financial health is supported by its ability to generate consistent operating cash flow, ensuring stability in meeting debt obligations and funding dividends.

Growth Trends And Dividend Policy

CNO has demonstrated steady growth in premiums and fee income, benefiting from demographic trends favoring retirement and health-related products. The company’s dividend policy, with a payout of $0.64 per share, reflects a commitment to returning capital to shareholders while retaining sufficient earnings for reinvestment. This balanced approach aligns with its long-term strategy of sustainable growth and shareholder returns.

Valuation And Market Expectations

The market values CNO based on its ability to deliver consistent earnings and cash flow in a competitive insurance landscape. Current metrics suggest investor confidence in its niche market focus and disciplined underwriting. The company’s valuation reflects expectations of stable growth, supported by its middle-market positioning and aging demographic tailwinds.

Strategic Advantages And Outlook

CNO’s strategic advantages include its targeted market focus, multi-channel distribution, and cost-efficient operations. The outlook remains positive, driven by demand for retirement and health insurance products among middle-income Americans. The company is well-positioned to capitalize on demographic trends, though regulatory and competitive pressures remain key considerations for sustained performance.

Sources

10-K, investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount